A paper by Twila Brase, RN, PHN, president of the Minnesota-based Citizens Council on Health Care, and published by ALEC, explains the dangers of relying solely on “evidence based medicine” (EBM) to determine appropriate treatment for an individual patient. The problems are too long to list here, but they include:
- Researcher bias when the researcher conducting the study has a preference for one form of treatment over another. Sometimes this may involve financial incentives, but that is not the only or even the major source of bias.
- Conflicting results. This happens all the time in research. One study contradicts another, and neither may be completely accurate.
- The expense, and therefore the rarity, of conducting randomized clinical trials. Very little medicine would be conducted if these trials controlled what could be done.
- Comorbidities. Clinical trials focus on only one condition at a time, but few patients present with just one issue. There is a little information available about how multiple conditions and multiple treatments interact.
- Special interest pleading. Well-organized interest groups are able to influence what topics are researched and how the research is conducted.
- Lack of real-world testing. What works in the lab may break down on the battlefield of real life. Continue reading Evidence-Based Medicine
Approximately 25% of consumers who are given a choice of plans choose an HSA-eligible product, but the percentage choosing an HRA has dropped from 23% in 2007 to 12% in 2008.
